EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of the COVID-19 restrictions on the epidemiology of Cryptosporidium spp. in England and Wales, 2015–2021: a time series analysis

James P Adamson, Rachel M Chalmers, Daniel Rh Thomas, Kristin Elwin, Guy Robinson, Alicia Barrasa

Journal of Medical Microbiology · 07.06.2023 · 72 (6)

DOI: 10.1099/jmm.0.001693 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 07.06.2023. Verfasst von James P Adamson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Communicable Disease Surveillance Centre, Public Health Wales, Cardiff, UK. Hauptthemen laut MEDLINE: Cryptosporidium, Cryptosporidiosis, COVID-19, Cryptosporidium parvum. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In England and Wales, cryptosporidiosis cases peak in spring and autumn, associated with zoonotic/environmental exposures ( Cryptosporidium parvum, spring/autumn) and overseas travel/water-based activities ( Cryptosporidium hominis, autumn). Coronavirus disease 2019 (COVID-19) restrictions prevented social mixing, overseas travel and access to venues (swimming pools/restaurants) for many months, potentially increasing environmental exposures as people sought alternative countryside activities. Hypothesis. COVID-19 restrictions reduced incidence of C. hominis cases and potentially increased incidence of C. parvum cases.

Aim

To inform/strengthen surveillance programmes, we investigated the impact of COVID-19 restrictions on the epidemiology of C. hominis and C. parvum cases. Methodology. Cases were extracted from the Cryptosporidium Reference Unit (CRU) database (1 January 2015 to 31 December 2021). We defined two periods for pre- and post-COVID-19 restrictions implementation, corresponding to before and after the first UK-wide lockdown on 23 March 2020. We conducted a time series analysis, assessing differences in C. parvum and C. hominis incidence, trends and periodicity between these periods.

Results

There were 21 304 cases ( C. parvum =12 246; C. hominis =9058). Post-restrictions implementation incidence of C. hominis dropped by 97.5 % (95 % CI: 95.4–98.6 %; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryptosporidiumCryptosporidiosisCOVID-19Cryptosporidium parvumHumansWalesTime FactorsGenotypeCommunicable Disease ControlEngland

Stichwörter der Autor:innen

C. hominisC. parvumCOVID-19Cryptosporidiumepidemiologytime series analysis

Autor:innen und Institutionen

  • Communicable Disease Surveillance Centre, Public Health Wales, Cardiff, UK.
  • UK Field Epidemiology Training Programme, UK Health Security Agency, London, UK.
  • Cryptosporidium Reference Unit , Public Health Wales, Swansea, UK.
  • Swansea University Medical School, Swansea University, Swansea, UK.

Zitieren

APA

Adamson, J. P., Chalmers, R. M., Thomas, D. R., Elwin, K., Robinson, G., & Barrasa, A. (2023). Impact of the COVID-19 restrictions on the epidemiology of Cryptosporidium spp. in England and Wales, 2015–2021: a time series analysis. Journal of Medical Microbiology, 72(6). https://doi.org/10.1099/jmm.0.001693

Vancouver

Adamson JP, Chalmers RM, Thomas DR, Elwin K, Robinson G, Barrasa A. Impact of the COVID-19 restrictions on the epidemiology of Cryptosporidium spp. in England and Wales, 2015–2021: a time series analysis. Journal of Medical Microbiology. 2023;72(6). doi:10.1099/jmm.0.001693

BibTeX
@article{Adamson2023,
  author = {Adamson, James P and Chalmers, Rachel M and Thomas, Daniel Rh and Elwin, Kristin and Robinson, Guy and Barrasa, Alicia},
  title = {Impact of the COVID-19 restrictions on the epidemiology of Cryptosporidium spp. in England and Wales, 2015–2021: a time series analysis},
  journal = {Journal of Medical Microbiology},
  year = {2023},
  volume = {72},
  number = {6},
  doi = {10.1099/jmm.0.001693}
}
Kostenlos starten →